T3021
Tinidazole
Sign In to View Organizational & Contract Pricing.
Select a Size
About This Item
Empirical Formula (Hill Notation):
C8H13N3O4S
CAS Number:
Molecular Weight:
247.27
UNSPSC Code:
51101500
PubChem Substance ID:
EC Number:
243-014-4
MDL number:
SMILES string
CCS(=O)(=O)CCn1c(C)ncc1N(=O)=O
Looking for similar products? Visit Product Comparison Guide
General description
Chemical structure: imidazole
Regulatory Information
新产品
This item has
Choose from one of the most recent versions:
Already Own This Product?
Find documentation for the products that you have recently purchased in the Document Library.
C E Nord et al.
Infection, 11(1), 54-60 (1983-01-01)
Tinidazole is a 5-nitroimidazole with selective activity against anaerobic bacteria and protozoa. It is bactericidal at low concentrations and its spectrum covers most anaerobic bacteria and some capnophilic microorganisms. Anaerobic bacteria known to be resistant to tinidazole include anaerobic streptococci
Hyuk Soon Choi et al.
World journal of gastroenterology, 18(19), 2377-2382 (2012-06-02)
To compare the effectiveness of sequential therapy for Helicobacter pylori (H. pylori) infection with that of triple therapy of varying durations. The 460 patients enrolled in this study had H. pylori-associated gastritis or a gastric or duodenal ulcer. After screening
Horatio B Fung et al.
Clinical therapeutics, 27(12), 1859-1884 (2006-03-02)
Tinidazole, a structural analogue of metrondazole, is an antiprotozoal agent that has been widely used in Europe and developing countries for >2 decades with established efficacy and acceptable tolerability. It was recently approved by the US Food and Drug Administration
Arlene C Seña et al.
The Journal of infectious diseases, 206(3), 357-365 (2012-05-23)
Chlamydia trachomatis (CT), Mycoplasma genitalium (MG), and Trichomonas vaginalis (TV) are sexually transmitted infections (STIs) associated with nongonococcal urethritis (NGU). We assessed their predictors and persistence after treatment. We analyzed data from an NGU treatment trial among symptomatic heterosexual men
Alessandro Federico et al.
Gastroenterology, 143(1), 55-61 (2012-04-10)
Helicobacter pylori have become resistant to antimicrobial agents, reducing eradication rates. A 10-day sequential regimen that contains levofloxacin was efficient, safe, and cost saving in eradicating H pylori infection in an area with high prevalence of clarithromycin resistance. We performed
Our team of scientists has experience in all areas of research including Life Science, Material Science, Chemical Synthesis, Chromatography, Analytical and many others.
Contact Technical Service